Tapering TNF inhibitors is safe and maintains low disease activity for 2 years in psoriatic arthritis and axial ...

Objectives The reproductive health of men with inflammatory joint disease (IJD) has been a topic of debate in recent years, ...

Among patients with PsA, MetS was independently associated with a D2T phenotype, even when accounting for fibromyalgia and disease activity.

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.

Health experts reveal the impact of the inflammatory skin condition on joints, and highlight symptoms and management tips ...

Whether it's short or long term, she suggests finding someone you trust to process the complicated feelings that emerge while living with an autoimmune disease. There's no need to keep all the ups and ...

In this video, Philip J. Mease, MD, discusses the potential for the development of a T-cell engaging antibody.

In this video, Philip J. Mease, MD, discusses results from the phase 2 ARGO clinical trials of sonelokimab for psoriatic arthritis, presented at the EULAR 2025 Congress.

Patients with late-onset SpA, initially diagnosed as polymyalgia rheumatica, may not respond well to glucocorticoids or ...

DelveInsight's TYK2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

EDITOR’S LETTER AUGUST 2025 The Advocacy Issue Personal narratives and science-backed storytelling on life with chronic ...

The Ankylosing Spondylitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from ...